Baker Botts – Kinder Morgan Energy Partners Completes $1.7 Billion Acquisition From Kinder Morgan, Inc.

On March 1, 2013, Kinder Morgan Energy Partners, L.P. (“KMP”) closed the acquisition of 50% of the outstanding equity interests in El Paso Midstream Investment Company, L.L.C. (“EPMIC”), and 50% of the outstanding equity interests in El Paso Natural Gas Company, L.L.C. (“EPNG”) from Kinder Morgan, Inc. (“KMI”).

More >>

Tags:  Baker Botts L.L.P. | Houston

Dechert Advises OCI Solar Power on Major Texas Solar Power Project

A cross-border team of lawyers at international law firm Dechert LLP advised OCI Solar Power, an emerging leader in the solar sector and an indirect subsidiary of Korean chemicals company OCI Company Ltd., on the financing of the first phase of its 400MW solar power plant development project in the City of San Antonio. Debt financing for the first phase, comprised of a 41MW solar power plant on more than 700 acres in the southern part of San Antonio, was arranged by Korean Finance Corporation and the Korea Development Bank acting as joint financial arrangers.

More >>

Tags:  Dechert LLP | Hong Kong

Paul Hastings Representing Samsung Electronics in US$110 Million Investment in Sharp Corp.

Paul Hastings, a leading global law firm, announced today that it is representing Samsung Electronics, a world leader in advanced semiconductor solutions, on its 10.4 billion yen (approximately US$110 million) investment – or 3 percent equity interest – in Sharp Corporation, the Japanese manufacturer of electronics goods and components, including liquid crystal displays. The parties entered into a definitive agreement on March 6, 2013 and expect to close the transaction, which marks the first capital tie-up between the two major consumer electronics makers, after satisfying regulatory procedures.

More >>

Tags:  Paul Hastings, LLP | Tokyo

Paul Hastings Represents Lead Arrangers in Pharmaceutical Research Associates, Inc. Financing

Paul Hastings LLP, a leading global law firm, announced today that the firm represented UBS Securities LLC, Wells Fargo Securities, LLC and General Electric Capital Corporation, as lead arrangers, and UBS AG, Stamford Branch, as administrative agent, in connection with the amendment of the existing amended and restated first lien credit agreement and the second lien credit agreement for Pharmaceutical Research Associates, Inc., to, among other things, permit the incurrence of first lien incremental term loans and second lien incremental term loans for the purposes of, among other things, the payment of a shareholder dividend and the acquisition of ClinStar, LLC.

More >>

Tags:  Paul Hastings, LLP | New York

Davis Polk Advises Digicel Limited on Notes Offering and Cash Tender Offer

Davis Polk advised Digicel Limited (Digicel) in connection with the offering by Digicel of an aggregate of $1 billion of Digicel’s 6% senior notes due 2021 and a concurrent cash tender offer by Digicel for any and all of its 12% senior notes due 2014. The notes were sold pursuant to Rule 144A and Regulation S under the Securities Act of 1933. The tender offer consideration was funded from the net proceeds of the offering.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk Advises Equinix, Inc. on Its $1.5 Billion High-Yield Notes Offering

Davis Polk advised Equinix, Inc. on its SEC-registered offering of $500 million aggregate principal amount of its 4.875% senior notes due 2020 and $1 billion aggregate principal amount of its 5.375% senior notes due 2023. J.P. Morgan Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc. acted as joint book-running managers for the offering.

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley